ABBVIE INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 167.9 USD | +0.65% |
|
+1.37% | +8.57% |
| Apr. 25 | Cigna to offer Humira rivals with $0 copay at specialty pharmacy | RE |
| Apr. 25 | AbbVie Says Rinvoq Shows Superiority Versus Dupixent in Atopic Dermatitis Trial Primary Endpoint | MT |
Quotes 5-day view
Delayed Quote London S.E.| 2024-04-22 | 2024-04-23 | 2024-04-24 | 2024-04-25 | 2024-04-26 | |
|---|---|---|---|---|---|
| Last | 169.265 $ | 170.11 $ | 168.16 $ | 167.29 $ | 167.9 $ |
| Volume | 2 457 577 | 738 782 | 206 873 | 3 211 | 0 |
| Change | +2.21% | +0.50% | -1.15% | -0.52% | +0.65% |
| Opening | 166.56 | 168.12 | 170.18 | 167.89 | 167.9 |
| High | 169.49 | 170.33 | 169.54 | 169.22 | 167.9 |
| Low | 166.41 | 167.89 | 166.90 | 165.62 | 167.9 |
Performance
| 1 day | +0.65% | ||
| 1 week | +1.37% | ||
| Current month | -7.46% | ||
| 1 month | -6.34% | ||
| 3 months | +2.34% | ||
| 6 months | +15.39% | ||
| Current year | +8.57% | ||
| 1 year | +3.97% | ||
| 3 years | +50.64% | ||
| 5 years | +132.72% | ||
| 10 years | +362.57% |
Volumes
marketsDaily volume
0
Estimated daily volume
0
Avg. Volume 20 sessions
88
Daily volume ratio
0.00
Avg. Volume 20 sessions USD
14 772.56
Record volume 1
2 872 186
Record volume 2
2 457 577
Record volume 3
1 952 793
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
296 211 533 786
Net sales (USD)
54 318 000 000
Number of employees
50 000
Sales / Employee (USD)
1 086 360
Free-Float
96.75 %
Free-Float capitalization (USD)
295 836 352 503
Average Daily Capital Traded
0%
Highs and lows
1 week
165.62
170.33
1 month
160.00181.62
Current year
154.54182.72
1 year
130.98182.72
3 years
105.59182.72
5 years
56.90182.72
10 years
36.29182.72
Indicators
Moving average 5 days
167.60
Moving average 20 days
170.33
Moving average 50 days
175.00
Moving average 100 days
167.43
Price spread / (MMA5)
-0.16%
Price spread / (MMA20)
+1.46%
Price spread / (MMA50)
+4.25%
Price spread / (MMA100)
-0.26%
STIM
RSI 9 days
49.83
RSI 14 days
45.66
Sector Comparison - Other Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +0.65% | +1.37% | +8.57% | +3.97% | 296B | ||
| +0.12% | +0.69% | +24.94% | +56.98% | 556B | ||
| -1.15% | +0.74% | -6.33% | -11.12% | 354B | ||
| +2.93% | +4.38% | +19.90% | +12.18% | 331B | ||
| -0.25% | +9.76% | +13.34% | +1.44% | 233B | ||
| -0.51% | +4.71% | +5.53% | -2.29% | 201B | ||
| +0.39% | -1.08% | -10.14% | -20.01% | 193B | ||
| -3.84% | -0.51% | -12.26% | -35.77% | 143B | ||
| -1.33% | +2.52% | -6.47% | +10.01% | 144B | ||
| -0.19% | +5.17% | +1.80% | -10.85% | 123B | ||
| -8.51% | -7.45% | -12.88% | -36.36% | 90.6B | ||
| -2.70% | -1.35% | -19.43% | -23.74% | 81.39B | ||
| +0.18% | +2.66% | +13.19% | +13.82% | 83.75B | ||
| -.--% | +1.73% | - | - | 63.66B | ||
| +5.12% | +8.07% | +29.39% | +6.39% | 58.76B | ||
| -0.16% | -1.40% | -9.17% | +42.08% | 51.41B | ||
| Average | +0.06% | +1.89% | +2.67% | +0.45% | ||
| Weighted average by Cap. | +0.15% | +2.38% | +6.85% | +7.63% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | +8.20% | ||
| 2023 | -3.58% | ||
| 2022 | +18.05% | ||
| 2021 | +30.14% | ||
| 2020 | +32.60% | ||
| 2019 | -2.19% | ||
| 2018 | -12.04% | ||
| 2017 | +51.94% | ||
| 2016 | +10.25% | ||
| 2015 | -2.44% | ||
| 2014 | +42.54% | ||
| 2013 | +60.82% |
- Stock Market
- Equities
- ABBV Stock
- 0QCV Stock
- Quotes AbbVie Inc.
